Real-World Data and the Benefits of External Control Arms
The expansion of real-world data (RWD) in regulatory decision-making, spurred on in the US by the 21st Century Cures Act, [...]
RCTs vs. RWE? Why Not Both?
Aetion Co-Founder and President Jeremy Rassen in a recent blog post discusses a new paradigm in which randomized controlled trials [...]
Study Finds ‘Moderate Agreement’ of Bias Assessment Using Data- and Opinion-Based Methods
A recent study suggests there's "moderate agreement" between opinion- and data-based assessments of bias in randomized trials. The study was [...]
Randomization vs. Real-World Evidence
Nonrandomized observational studies have been touted by some as being a viable alternative to randomized clinical trials, but are they [...]